Currently out of the existing stock ratings of Swayampakula Ramakanth, 364 are a BUY (94.55%), 19 are a HOLD (4.94%), 2 are a SELL (0.52%).

Swayampakula Ramakanth

Work Performance Price Targets & Ratings Chart

Analyst Swayampakula Ramakanth, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 29.54% that have a potential upside of 47.8% achieved within 157 days.

Swayampakula Ramakanth’s has documented 730 price targets and ratings displayed on 55 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on IPHA, Innate Pharma at 17-Jan-2025.

Wall Street Analyst Swayampakula Ramakanth

Analyst best performing recommendations are on QSI (QUANTUMSI).
The best stock recommendation documented was for QSI (QUANTUMSI) at 11/13/2024. The price target of $4 was fulfilled within 50 days with a profit of $3.19 (393.83%) receiving and performance score of 78.77.

Average potential price target upside

of $355.5 (77.04%) on TCRT (ALAUNOS THERAPEUTICS).
of $43 (57.15%) on TARA (PROTARA THERAPEUTICS).
of $17.39 (120.01%) on JANX (JANUX THERAPEUTICS).

EKSO Ekso Bionics Holdings PGEN Precigen TRIL Trillium Therapeutics VSTM Verastem BCAB Bioatla BCYC Bicycle Therapeutics Ltd CALA Calithera Biosciences CDXS Codexis HARP Harpoon Therapeutics HOOK Hookipa Pharma ITOS Iteos Therapeutics MDXG MiMedx Group OCGN Ocugen PLSE Pulse Biosciences DCTH Delcath Systems ECOR Electrocore LLC MDNA Medicenna Therapeutics Corp PSNL Personalis SURF Surface Oncology VOR Vor Biopharma XFOR X4 Pharmaceuticals CORT Corcept Therapeutics MDWD Mediwound Ltd ONCR Oncorus IMGN ImmunoGen AFMD Affimed NV ALXO Alx Oncology Holdings ASXC Asensus Surgical CELU Celularity EDAP EDAP TMS SA INAB In8bio IPA Immunoprecise Antibodies Ltd LPTX Leap Therapeutics RWLK Rewalk Robotics Ltd SRGA Surgalign Holdings VCEL Vericel Corp Ord ABSI Absci Corp AVGR Avinger IPHA Innate Pharma JANX Janux Therapeutics TCRT Alaunos Therapeutics ATEC Alphatec Holdings AVEO AVEO Pharmaceuticals CASI CASI Pharmaceuticals CLRB Cellectar Biosciences PSTI Pluristem QSI QuantumSi JNCE Jounce Therapeutics KIN Kindred Biosciences SESN Sesen Bio TARA Protara Therapeutics MESO Mesoblast Ltd VBLT Vascular Biogenics Ltd EVAX Evaxion Biotech AS RDHL Redhill Biopharma Ltd

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Swayampakula Ramakanth (HCWAINWRIGHT)

Buy

$10

$8.96 (861.54%)

$10

5 months 21 days ago
(30-Jul-2024)

1/5 (20%)

$8.94 (843.40%)

671

Please subscribe to see the analyst performance score

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Swayampakula Ramakanth is most bullish on?

Potential upside of $29.28 has been obtained for JANX (JANUX THERAPEUTICS)

Which stock is Swayampakula Ramakanth is most reserved on?

Potential downside of $0.93 has been obtained for VCEL (VERICEL CORP ORD)

What Year was the first public recommendation made by Swayampakula Ramakanth?

On 2015